Arrow Teleflex Recalls 847 Chronic Hemodialysis Catheters
Summary
ANSM was notified that Arrow International Inc / Teleflex has initiated a product withdrawal (recall action registered as R2610908) affecting chronic hemodialysis catheters. The recall encompasses 847 units across seven product lines including Arrow Edge, Arrow-Clark VectorFlow, Cannon II Plus, and NextStep catheters in both antegrade and retrograde configurations. Healthcare facilities and nephrologists using these devices have been contacted directly via letter from the manufacturer.
“L'ANSM a été informée de la mise en œuvre d'un retrait de produit effectué par la société Arrow International Inc / Teleflex.”
About this source
GovPing monitors ANSM Drug & Device Safety Alerts for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 101 changes logged to date.
What changed
Arrow International Inc / Teleflex has initiated a product withdrawal for chronic hemodialysis catheters, as registered with ANSM under reference R2610908. The recall affects 847 units spanning seven product lines distributed to healthcare facilities and nephrology practices. ANSM has confirmed that concerned users have received direct notification from the manufacturer. Healthcare providers and dialysis centers should verify their inventory against the listed product names (Arrow Edge, Hemodialysis Catheterization Product, Arrow-Clark VectorFlow Antegrade and Retrograde, Cannon II Plus, NextStep Antegrade and Retrograde) and follow any instructions provided in the manufacturer's direct correspondence.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Rappel n° R2610908 destiné aux établissements de santé, centres de santé, médecins néphrologues L'ANSM a été informée de la mise en œuvre d’un retrait de produit effectué par la société Arrow International Inc / Teleflex.
Les utilisateurs concernés ont reçu le courrier ci-joint.
Cette action de sécurité est enregistrée à l’ANSM sous le n° R2610908. Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité.
Les produits concernés sont :
- Arrow Edge
- Hemodialysis Catheterization Product
- Arrow-Clark VectorFlow Antegrade Chronic Hemodialysis Catheter
- Arrow-Clark VectorFlow Retrograde Chronic Hemodialysis Catheter
- Cannon II Plus Chronic Hemodialysis Catheter
- NextStep Antegrade Chronic Hemodialysis Catheter
- NextStep Retrograde Chronic Hemodialysis Catheter
Téléchargez le courrier de la société Arrow International Inc / Teleflex (22/04/2026)
Related changes
Get daily alerts for ANSM Drug & Device Safety Alerts
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from ANSM.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.